89 related articles for article (PubMed ID: 8230980)
1. [Doxazosin (alpha 1-adrenoreceptor antagonist) used in primary hypertension and it's beneficial effect on lipid metabolism].
Sznajderman M; Chotkowska E; Peczkowska M; Sawicki M; Janaszek-Sitkowska H; Wiernikowska-Wegorek I; Galewicz A; Cybulska I
Kardiol Pol; 1993 Feb; 38(2):107-11. PubMed ID: 8230980
[TBL] [Abstract][Full Text] [Related]
2. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
[TBL] [Abstract][Full Text] [Related]
3. Combined effect of doxazosin and pindolol on blood pressure control and lipid concentrations in patients with essential hypertension selected from general practice. Hunter Hypertension Research Group.
J Hum Hypertens; 1992 Jun; 6(3):181-4. PubMed ID: 1352827
[TBL] [Abstract][Full Text] [Related]
4. [Doxazosin in the treatment of light-to-moderate arterial hypertension in a non-comparative multicenter study].
Pessina AC
Clin Ter; 1995 Jan; 146(1):3-12. PubMed ID: 7705011
[TBL] [Abstract][Full Text] [Related]
5. [Doxazosin for the treatment of arterial hypertension].
Mozzato MG; Semplicini A; Serena L; Valle R; Casolino P; Buzzaccarini F; Rubino N; Giusto M; Pessina AC
Cardiologia; 1990 Nov; 35(11):931-6. PubMed ID: 2151571
[TBL] [Abstract][Full Text] [Related]
6. Doxazosin GITS versus standard doxazosin in mild to moderate hypertension.
Calvo C; Gil-Extremera B; Gomez-Fernández P; Masramon X; Pueyo C; Armada B
Int J Cardiol; 2005 May; 101(1):97-104. PubMed ID: 15860390
[TBL] [Abstract][Full Text] [Related]
7. Effects of doxazosin on hemorheological, hemodynamic and lipid parameters in patients with essential hypertension.
Toth K; Nemes J; Czopf L; Kapronczay P; Kesmarky G; Juricskay I
Clin Hemorheol Microcirc; 1999; 20(1):57-61. PubMed ID: 11185685
[TBL] [Abstract][Full Text] [Related]
8. [The effect of doxazosin on blood pressure, lipids, fibrinogen and plasminogen activator inhibitor. A comparative study among smokers and non-smokers with essential hypertension].
Daae LN; Kierulf P; Brusletto B; Westheim A; Holme I; Syvertsen JO
Tidsskr Nor Laegeforen; 1991 Apr; 111(9):1102-5. PubMed ID: 1827216
[TBL] [Abstract][Full Text] [Related]
9. Hemorheological and hemodynamic parameters in patients with essential hypertension and their modification by alpha-1 inhibitor drug treatment.
Toth K; Kesmarky G; Vekasi J; Nemes J; Czopf L; Kapronczay P; Halmosi R; Papp E; Juricskay I
Clin Hemorheol Microcirc; 1999; 21(3-4):209-16. PubMed ID: 10711745
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of essential arterial hypertension with hypercholesterolemia. Effects of an alpha-adrenergic blocker and an inhibitor of the angiotensin converting enzyme].
Fernández Pinilla C; Luque Otero M; Martell Claros N; Alcázar de la Osa JM; Rodicio Díaz JL; Ruilope Urioste LM
Med Clin (Barc); 1993 Jun; 101(5):168-71. PubMed ID: 8332009
[TBL] [Abstract][Full Text] [Related]
11. Combined effect of a low fat diet and doxazosin on blood pressure control and blood lipids. Hunter Hypertension Research Group.
J Hum Hypertens; 1994 Dec; 8(12):907-10. PubMed ID: 7884789
[TBL] [Abstract][Full Text] [Related]
12. Effects of selective alfa 1 and beta 1-adrenoreceptor blockade on lipoprotein and carbohydrate metabolism in hypertensive subjects, with special emphasis on insulin sensitivity.
Andersson PE; Johansson J; Berne C; Lithell H
J Hum Hypertens; 1994 Mar; 8(3):219-26. PubMed ID: 8006923
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug.
Ohta Y; Tsuchihashi T; Onaka U; Eto K; Ueno M
Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy and tolerance of doxazosin in the treatment of isolated systolic hypertension in hypertensive patients over 60 years of age].
Calvo C; López E; Barrio E; Espejo J; Ruiz M; Vega A
An Med Interna; 1995 Mar; 12(3):122-6. PubMed ID: 7795118
[TBL] [Abstract][Full Text] [Related]
15. A randomized, controlled, multicenter study to compare prazosin GITS with enalapril in hypertensive patients with diabetes mellitus. Bombay Hypertension Study Group.
Joglekar SJ; Nanivadekar AS
J Assoc Physicians India; 1998; Suppl 1():52-62. PubMed ID: 11233387
[TBL] [Abstract][Full Text] [Related]
16. Multicentric, clinical trial of S-Amlodipine 2.5 mg versus Amlodipine 5 mg in the treatment of mild to moderate hypertension--a randomized, double-blind clinical trial.
Pathak L; Hiremath ; Kerkar PG; Manade VG
J Assoc Physicians India; 2004 Mar; 52():197-202. PubMed ID: 15636308
[TBL] [Abstract][Full Text] [Related]
17. [Reducing blood pressure and modification of coronary risk factors by therapy with doxazosin].
Hitzenberger G; Ganzinger U
Wien Klin Wochenschr; 1993; 105(13):371-6. PubMed ID: 8351927
[TBL] [Abstract][Full Text] [Related]
18. Add-on effect of bedtime dosing of the alpha(1)-adrenergic receptor antagonist doxazosin on morning hypertension and left ventricular hypertrophy in patients undergoing long-term amlodipine monotherapy.
Ikeda T; Gomi T; Shibuya Y; Shinozaki S; Suzuki Y; Matsuda N
Hypertens Res; 2007 Nov; 30(11):1097-105. PubMed ID: 18250559
[TBL] [Abstract][Full Text] [Related]
19. Doxazosin in hypertension: results of a general practice study in 4809 patients.
Langdon CG; Packard RS
Br J Clin Pract; 1994; 48(6):293-8. PubMed ID: 7848789
[TBL] [Abstract][Full Text] [Related]
20. Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension.
Levine B
Curr Med Res Opin; 2001; 17(1):8-17. PubMed ID: 11464450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
